Walpar Nutritions IPO Details

Walpar Nutritions IPO Walpar Nutritions IPO description – Walpar Nutritions offers a wide range of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The company develops, manufactures and commercializes HERBO-NUTRACEUTICAL products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under Nutraceuticals.

The company has product approvals under the license issued by FSSAI (Food Safety and Standards Authority of India) and AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) department for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology.

Walpar has developed more than 100 formulations and 1000 brands for third party for domestic market under different segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Sports nutrition.WALPAR manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet, powders and effervescent tablets.

Its manufacturing unit is located at 4-9, and 21 at Shyam Estate, Santej, Ta: Kalol, Gandhinagar. At present, the company has installed capacity of manufacturing of approx. 30 Lakhs tablets per month, 12.50 Lakhs capsules per month, 1.50 Lakhs oral liquids of (ranging from 15 ML to 200 ML) per month, and 2.00 Lakhs Sachets of (ranging from 1 gm to 10 gms) per month. It holds WHO, HACCP, HALAL, Kosher and ISO 9001:2015 certificate issued by Independent agencies and has also applied for patents for three products.

Promoters of Walpar Nutritions – Mr Kalpesh Pravinchandra Ladhawala, Mr Tanmaykumar Ashwinbhai Shah And Mrs Sejal Kalpesh Ladhawala
Walpar Nutritions IPO details
Subscription Dates 30 June – 5 July 2021
Price Band INR55 per share
Fresh issue 1,200,000 shares (INR6.60 crore)
Offer For Sale Nil
Total IPO size 1,200,000 shares (INR6.60 crore)
Minimum bid (lot size) 2,000 shares
Face Value  INR10 per share
Retail Allocation 50%
Listing On NSE Emerge SME platform

Walpar Nutritions financial performance (in INR lakhs)

  FY2018 FY2019 FY2020 9M FY2021
Revenue 644.53 1,282.27 1,671.27 1,278.75
Expenses 641.77 1,270.46 1,652.25 1,239.60
Net income 0.33 6.88 12.18 28.55
Net margin (%) 0.1 0.5 0.7 2.2

Registrar of Walpar Nutritions IPO

Skyline Financial Services Pvt Ltd
A/505, Dattani Plaza,
Andheri Kurla Road Safeed Pool
Andheri (E), Mumbai- 400072
Maharashtra, India 
Phone: +91 22 2851 1022
Email[email protected]
Website: www.skylinerta.com

Valuation of Walpar Nutritions IPO (FY2020)

Earnings Per Share (EPS): INR0.41
Price/Earnings (PE ratio): 135.44
Return on Net Worth (RONW): 6.53%
Net Asset Value (NAV): INR6.22 per share

Walpar Nutritions IPO Subscription Details


Subscription (no. of times)

Day 1


Day 2


Day 3


Day 4



Walpar Nutritions Contact Details

Walpar Nutritions Limited
2nd Floor, L5: 377 PLOT:5,
Opp. Sabarmati, Khatraj,
Taluka kalol, Gandhinagar-382721
Phone: +91 2764 662626
Email: [email protected]
Website: www.walparnutritions.com

Walpar Nutritions IPO Allotment Status

Walpar Nutritions IPO allotment status is now available on Skyline Financial Services’ website. Click on this link to get allotment status. 

Listing Performance of Walpar Nutritions

IPO Opening Date: 30 June 2021
IPO Closing Date: 5 July 2021
Finalisation of Basis of Allotment: 8 July 2021
Initiation of refunds:
9 July 2021 
Transfer of shares to demat accounts:
9 July 2021 
Listing Date
: 13 July 2021 
Opening Price on NSE SME: INR59.95 per share (up 9% from IPO price)
Closing Price on NSE SME: INR57.00 per share (up 3.64% from IPO price)


Please enter your comment!
Please enter your name here

Brokerage-free IPO Investing